HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Business Lobby Opposes Retroactivity If Congress Restores FTC Monetary Relief Authority

Executive Summary

US Chamber of Commerce’s position to deny retroactive applicability in collecting monetary relief under the FTC Act against advertising violators would provide a “gaping loophole” for violators to escape consequences and encourage future misdeeds, says FTC acting chairwoman Rebecca Kelly Slaughter.

You may also be interested in...

Manchin’s Build Back Better Battle Could Sink Restoring FTC Monetary Relief Authority

Members of Congress in favor of giving FTC authority to impose monetary relief orders against firms linked to false advertising likely were caught off guard when West Virginia Democrat said he wouldn’t vote for legislation with $2.2 trillion for climate change, tax and social programs that President Biden made a primary plank of his Capitol Hill strategy and that the House passed in November.

Sharper Cut May Be Needed For Legislation Restoring FTC’s Monetary Relief Authority

Only bill introduced in Congress on amending Sec. 13(b) of FTC rules to restore authority would make all pending false advertising enforcements subject to the authority. H.R. 2668 also would allow FTC to target advertising as far back as 10 years from when it files a complaint.

Congressional Split Looms Over Including Retroactive Reach In FTC Monetary Relief Authority

Lawmakers disagree whether legislation to amend an FTC regulation to grant the commission authority to pursue monetary remedies should be retroactive, which would impact approximately 75 pending federal court cases alleging violations.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts